1. Build a Strong Employer BrandFirst up, let’s talk about your employer brand. Think of it as your company’s personality and reputation. In Japan’s competitive pharmaceutical and medical device industry, it’s crucial to stand out. You need to showcase your…
HOME > REGULATORY
REGULATORY
- Ex-Min. Tamura’s Study Group Boots Up with Backing of 17 Healthcare-Related Organizations
April 7, 2017
- Domestic Drug Production Logs 1st Rise in 4 Years: 2015 MHLW Survey
April 6, 2017
- Rare Symposium Planned after Closed-Door Regulatory Head Confab in October
April 6, 2017
- AMED Inks Collaboration Pact with Spanish Authority
April 6, 2017
- “I Don’t Use Biosimilars,” Says Ex-Chief of Japan College of Rheumatology
April 5, 2017
- MHLW Releases “Blue Book” Generic Data List
April 4, 2017
- MHLW Sets Up Office for Startup Support, Starts Receiving Applications for Consultations
April 4, 2017
- MHLW Issues Optimal Use Guidelines for Repatha, Praluent
April 3, 2017
- MHLW to Launch Conditional Early Approval for Medical Devices Too
April 3, 2017
- Cabinet Presents Reform of Drug Discovery Support Network Including Use of CROs, Transfer of Drug Makers’ Employees
April 3, 2017
- Avigan Might Be Used for Pandemic Influenza if Existing NA Inhibitors Are Ineffective: Expert Council
April 3, 2017
- CEFP Kicks Off Discussions on Economic and Fiscal Policy Blueprint for 2017
March 31, 2017
- Members of New Counterfeits Panel Call for Eliminating Cash-and-Carry Dealers
March 31, 2017
- Clinical Research Bill Likely to Clear Diet Early April
March 31, 2017
- MHLW Approves Ninlaro, Intuniv, Other Drugs
March 31, 2017
- MHLW to Set up New Council to Discuss Safety Measures for Pharmacotherapy in the Elderly
March 31, 2017
- Drug Price Survey Sheets to Be Distributed with No Prefectural Govts In-Between: Chuikyo
March 30, 2017
- AMED Racks Up 1st Out-Licensing Cases in Drug Discovery Support Initiative
March 30, 2017
- Chuikyo Gives Ex-Post Nod to Opdivo’s Optimal Use Guidelines for Head-and-Neck Cancer
March 30, 2017
- CDISC-Based Electronic Submissions for 19 Products Since October: PMDA
March 29, 2017
ページ
In late January, a bill to amend the Pharmaceuticals and Medical Devices Act cleared key legislation review processes by the…
A Japanese health ministry panel on December 26 wrapped up its discussions on the next amendment of the Pharmaceuticals and…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s key reimbursement policy panel on December 25 approved an outline of the FY2025 drug price revision, finalizing plans to…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…
A Japanese health ministry study group focused on pharmaceutical regulations on March 21 agreed on a policy to encourage the…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…